Found 7 matching trials
HUMC 1612: Optune NovoTTF-200A System
PHASE1The purpose of this study is to determine if the Optune NovoTTF-200A device...
Location
Arnold Palmer Hospital for Children
Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG
NAThis is a multicenter trial of the Optune device to examine the feasibility...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma
PHASE2Phase I/II trial in which participants with recurrent glioblastoma will rec...
Location
Miami Cancer Institute at Baptist Health, Inc.
Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma
EARLY_PHASE1This pilot early phase I trial studies the side effects of temozolomide, ra...
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
PHASE1The purpose of this study is to use precision medicine in the form of a vac...
Status
Active Not Recruiting
Location
Albert Einstein College of Medicine
NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
PHASE1This study is a prospective single arm trial designed to study the safety, ...
Location
John Theurer Cancer Center at Hackensack University Medical Center
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
PHASE2The purpose of this research study is to determine the effects bevacizumab ...
Location
John Wayne Cancer Center at Providence St. John's Health Center